FDA: Weight Loss Drug Possibly Linked to Cancer
Lorcaserin may potentially increase the risk of cancer, according to results from a clinical trial assessing the safety of the weight loss agent.
Lorcaserin may potentially increase the risk of cancer, according to results from a clinical trial assessing the safety of the weight loss agent.
Large study shows particular increase in the 50- to 64-year-old age group from 2000 to 2016.
One potentially revolutionary hypothesis relates to the evolutionary processes involved in oncogenesis.
Obesity in childhood and adolescence may be related to the disproportionate rise in certain obesity-related cancers in younger adults, according to authors.
This fact sheet reviews data on the effect of obesity on cancer risk and outcomes.
Having a high body mass index reduces the risk for developing breast cancer before menopause, but more research is needed to understand the biological mechanism.
Treatment options for obesity including strength, form, and dosing details.
A recent article is only the latest in a series of studies drawing attention to the importance of diet in prostate cancer development.
The median proportion of obese patients was 18%, as observed over 22 RCTs.
The longer a woman is overweight, the higher her risk of several cancers.